EP
AGN

Eudaimonia Partners’s Allergan plc AGN Stock Holding History

Eudaimonia Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-719
Closed -$127K – 773
2020
Q1 		$127K Buy
719
+583
+429% +$110K 0.06% 289
2019
Q4 		$26K Buy
+136
New +$24.5K 0.01% 633

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Eudaimonia Partners's AGN Position: Q2 2020 in Review

Eudaimonia Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 719 shares — an estimated $127K sold.

Eudaimonia Partners first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $127K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Eudaimonia Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Eudaimonia Partners sold 719 Allergan plc shares in Q2 2020, an estimated $127K.
  • Eudaimonia Partners first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Eudaimonia Partners's Allergan plc position peaked at $127K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Eudaimonia Partners's 13F filing for Q2 2020, filed 14 Aug 2020.